Eva Live Inc. reports developments in AI-driven digital advertising, marketing automation, and online lead generation. The company’s updates center on autonomous campaign management tools, including Eva Brain, NeuroServer, and Fast Quote Direct, which are designed for real-time campaign deployment, bid and budget optimization, audience targeting, fraud filtering, quoting, and customer acquisition workflows.
GOAI news also covers operating results, client adoption, product commercialization, financing activity, Nasdaq listing developments, and capital priorities. Recurring announcements connect the company’s advertising technology platform with enterprise marketing customers, lead-generation use cases, and the capital structure needed to support product expansion.
Eva Live (NASDAQ: GOAI) launched Eva Brain, a fully autonomous AI marketing agent that automates campaign creation, optimization, creative iteration, fraud detection, and model retraining across major ad platforms.
For year ended Dec 31, 2025, Eva Live reported $17,037,328 revenue (+82.6% YoY), $8,127,313 net income, and 20 active enterprise clients.
Eva Live (NASDAQ: GOAI) has engaged Anderson Kill P.C. to implement a Nasdaq tokenization strategy announced March 30, 2026. The company is preparing GOAI for tokenized securities trading by aligning equity, governance, custody, and settlement processes with SEC and Nasdaq requirements.
Key actions include structuring equity for token infrastructure, preparing eligibility for expanded tokenization cohorts, and establishing a capital-markets framework compatible with digital assets.
EVA Live (Nasdaq: GOAI) reported a transformational 2025: revenue of $17,037,328, up 82.6% year-over-year, and a swing to net income of $8,127,313 versus a $3,753,268 loss in 2024. Active clients rose 25% and operating expenses fell to 51.75% of revenue.
Management attributed results to higher advertiser spending, improved operating efficiencies, and platform scalability as the company positions for AI-driven product rollouts in 2026.
EVA Live (Nasdaq: GOAI) secured strategic growth financing from Streeterville Capital to accelerate its 2026 Growth Strategy. The funding is intended to speed product development, scale infrastructure, expand distribution, and commercialize AI platforms NeuroServer and FastQuoteDirect, with FastQuoteDirect currently in beta.
The company plans to use proceeds for engineering, platform enhancements, and targeted marketing to drive adoption of its AI-driven advertising and quoting solutions.
EVA Live (Nasdaq: GOAI) launched Fast Quote Direct™, a beta AI-powered quoting engine to replace static forms and convert high-intent traffic into qualified customers.
The platform is live in beta and will roll out commercially in phases throughout 2026, operating as both an integrated NeuroServer component and a standalone SaaS product. EVA Live cites a U.S. online lead generation market estimated at $1.6 billion to $3 billion.
EVA Live (Nasdaq: GOAI) launched the NeuroServer client-facing web application on Feb 17, 2026, its first interface for the company’s AI-driven ad server. The app, developed over two-plus years, has shown strong early enterprise adoption and is expected to drive revenue and recurring growth through 2026.
The platform offers centralized, real-time campaign management, fraud mitigation, AI-driven optimization, and onboarding for thousands of enterprise accounts; early results show up to 40% higher ROI for some clients.
EVA Live (Nasdaq: GOAI) founder and CEO David Boulette outlined a shift from development to commercialization after the company’s Nasdaq uplisting and the launch of NeuroServer, its AI-powered advertising platform. The company withdrew its previously filed Form S-1 and says it will prioritize disciplined capital management.
Management is evaluating a potential share repurchase program, subject to board approval, market conditions, and regulatory requirements, and has expanded engineering, product, and business development teams to support commercialization.
EVA Live (Nasdaq: GOAI) launched NeuroServe on February 3, 2026, a next-generation AI online advertising platform designed for enterprise-scale campaign optimization. The platform, developed for more than two years and BETA tested in 2025, uses real-time AI learning to automate targeting, reduce manual A/B testing, and improve return on ad spend. Management expects NeuroServe to become the company's leading product by sales by the end of 2026, subject to market conditions and execution. Live demonstrations are available via the company website.
EVA Live (Nasdaq: GOAI) began trading on Nasdaq on January 29, 2026, drawing notable investor and media attention following its listing.
The company promotes a fully proprietary AI ad server that operates across search engines and social media, claims superior learning capabilities, recurring revenue, nearly a decade of operation, and expansion progress ahead of deadlines by 15–20%.
EVA Live (NASDAQ: GOAI) announced it was approved to list on the Nasdaq Stock Market and will begin trading on January 28, 2026 under the existing ticker GOAI.
The uplisting aims to increase visibility with institutional investors, improve liquidity for shareholders, and reflects strengthened corporate governance and financial reporting. The company said no action is required by existing shareholders and trading will continue without interruption.